ALHC has 36-month beta value of 1.43. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ALHC is 90.54M, and currently, short sellers hold a 6.43% ratio of that float. The average trading volume of ALHC on June 19, 2024 was 930.11K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ALHC) stock’s latest price update
Alignment Healthcare Inc (NASDAQ: ALHC) has experienced a decline in its stock price by -4.43 compared to its previous closing price of 7.90. However, the company has seen a fall of -8.60% in its stock price over the last five trading days. globenewswire.com reported 2024-05-22 that ORANGE, Calif., May 22, 2024 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that John Kao, founder and CEO, and Thomas Freeman, chief financial officer, will present at William Blair’s 44th Annual Growth Stock Conference in Chicago on Wednesday, June 5, at 12:40 p.m. CDT.
ALHC’s Market Performance
ALHC’s stock has fallen by -8.60% in the past week, with a monthly rise of 3.99% and a quarterly rise of 52.83%. The volatility ratio for the week is 5.32% while the volatility levels for the last 30 days are 4.42% for Alignment Healthcare Inc The simple moving average for the past 20 days is -3.44% for ALHC’s stock, with a 13.47% simple moving average for the past 200 days.
Analysts’ Opinion of ALHC
Many brokerage firms have already submitted their reports for ALHC stocks, with BofA Securities repeating the rating for ALHC by listing it as a “Buy.” The predicted price for ALHC in the upcoming period, according to BofA Securities is $11 based on the research report published on May 30, 2024 of the current year 2024.
Robert W. Baird, on the other hand, stated in their research note that they expect to see ALHC reach a price target of $10. The rating they have provided for ALHC stocks is “Outperform” according to the report published on May 30th, 2024.
Piper Sandler gave a rating of “Overweight” to ALHC, setting the target price at $8 in the report published on May 08th of the current year.
ALHC Trading at 15.23% from the 50-Day Moving Average
After a stumble in the market that brought ALHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.91% of loss for the given period.
Volatility was left at 4.42%, however, over the last 30 days, the volatility rate increased by 5.32%, as shares surge +4.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +57.29% upper at present.
During the last 5 trading sessions, ALHC fell by -8.60%, which changed the moving average for the period of 200-days by +29.28% in comparison to the 20-day moving average, which settled at $7.84. In addition, Alignment Healthcare Inc saw -12.31% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALHC starting from JOYCE CHRISTOPHER J, who sale 16,000 shares at the price of $8.01 back on Jun 14 ’24. After this action, JOYCE CHRISTOPHER J now owns 422,912 shares of Alignment Healthcare Inc, valued at $128,198 using the latest closing price.
MARGOLIS JEFFREY H, the Director of Alignment Healthcare Inc, sale 1,200 shares at $8.06 during a trade that took place back on Jun 14 ’24, which means that MARGOLIS JEFFREY H is holding 415,933 shares at $9,672 based on the most recent closing price.
Stock Fundamentals for ALHC
Current profitability levels for the company are sitting at:
- -0.07 for the present operating margin
- 0.11 for the gross margin
The net margin for Alignment Healthcare Inc stands at -0.08. The total capital return value is set at -0.45. Equity return is now at value -88.91, with -22.55 for asset returns.
Based on Alignment Healthcare Inc (ALHC), the company’s capital structure generated 0.55 points at debt to capital in total, while cash flow to debt ratio is standing at -0.93. The debt to equity ratio resting at 1.24. The interest coverage ratio of the stock is -6.31.
Currently, EBITDA for the company is -105.3 million with net debt to EBITDA at 0.62. When we switch over and look at the enterprise to sales, we see a ratio of 0.68. The receivables turnover for the company is 12.2for trailing twelve months and the total asset turnover is 3.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.57.
Conclusion
To put it simply, Alignment Healthcare Inc (ALHC) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
